Resonant

Neurodegenerative disorders (NGDs) affect millions worldwide. Starting with Alzheimers, we are committed to creating novel testing solutions for early detection to provide clinicians, researchers, and individuals with the tools to effectively diagnose, treat, and manage NGDs.